These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4050621)

  • 1. Carrageenin-induced thrombosis in rats and mice: a model for testing antithrombotic substances?
    Bekemeier H; Hirschelmann R; Giessler AJ
    Agents Actions; 1985 Jul; 16(5):446-51. PubMed ID: 4050621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrageenin-induced thrombosis in the rat and mouse as a test model of substances influencing thrombosis.
    Bekemeier H; Hirschelmann R; Giessler AJ
    Biomed Biochim Acta; 1984; 43(8-9):S347-50. PubMed ID: 6517902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new low molecular weight heparan sulphate antagonizes kappa-carrageenan-induced thrombosis in rats.
    Gervasi GB; Bartoli C; Carpita G
    Pharmacol Res; 1991 Jul; 24(1):59-63. PubMed ID: 1658763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of serotonin, serotonin antagonists, some vasoactive substances and temperature on carrageenin-induced tail thrombosis in rats and mice.
    Bekemeier H; Hirschelmann R
    Agents Actions; 1986 Aug; 18(5-6):581-5. PubMed ID: 3766313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin and phenprocoumon inhibit kappa-carrageenin induced thrombosis in rats.
    Hirschelmann R; Bekemeier H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):379-82. PubMed ID: 2428713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving frequency of thrombosis by altering blood flow in the carrageenan-induced rat tail thrombosis model.
    Hagimori M; Kamiya S; Yamaguchi Y; Arakawa M
    Pharmacol Res; 2009 Oct; 60(4):320-3. PubMed ID: 19394423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological and ultrastructural changes of cardiomyocytes in experimental rats with tail thrombosis following subplantar application of carrageenin.
    Kod'ousek R; Jezdínský J; Krajcí D
    Med Princ Pract; 2007; 16(5):360-6. PubMed ID: 17709924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the antithrombotic effects of Crataegus monogyna and Crataegus davisii in the carrageenan-induced tail thrombosis model.
    Arslan R; Bektas N; Bor Z; Sener E
    Pharm Biol; 2015 Feb; 53(2):275-9. PubMed ID: 25243870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of flavonoids and lanthanides on kappa-carrageenin rat tail thrombosis.
    Bekemeier H; Gabor M; Hirschelmann R
    Exp Pathol; 1990; 40(1):61-3. PubMed ID: 2279536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation method of the effect of nattokinase on carrageenan-induced tail thrombosis in a rat model.
    Kamiya S; Hagimori M; Ogasawara M; Arakawa M
    Acta Haematol; 2010; 124(4):218-24. PubMed ID: 21071931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model.
    Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B
    Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antithrombotic fucoidan, unlike heparin, does not prolong bleeding time in a murine arterial thrombosis model: a comparative study of Undaria pinnatifida sporophylls and Fucus vesiculosus.
    Min SK; Kwon OC; Lee S; Park KH; Kim JK
    Phytother Res; 2012 May; 26(5):752-7. PubMed ID: 22084059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease.
    Hara H; Shimada H; Kitajima A; Tamao Y
    Arzneimittelforschung; 1991 Jun; 41(6):616-20. PubMed ID: 1930349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis (infarction) induced by kappa-carrageenin in rat tail: inhibition during adjuvant arthritis.
    Hirschelmann R; Bekemeier H
    Exp Pathol; 1987; 31(3):175-8. PubMed ID: 3609241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparin.
    Tapparelli C; Metternich R; Gfeller P; Gafner B; Powling M
    Thromb Haemost; 1995 Apr; 73(4):641-7. PubMed ID: 7495072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.
    Landucci EC; Antunes E; Donato JL; Faro R; Hyslop S; Marangoni S; Oliveira B; Cirino G; de Nucci G
    Br J Pharmacol; 1995 Feb; 114(3):578-83. PubMed ID: 7537590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of antithrombotics in a new model of arterial thrombosis.
    Hladovec J
    Thromb Res; 1986 Mar; 41(5):665-70. PubMed ID: 3961741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic action of recombinant hirudin in a venous thrombosis model.
    Raake W; Klauser RJ; Elling H; Zeiller P
    Haemostasis; 1991; 21 Suppl 1():127-32. PubMed ID: 1654293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
    Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
    Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between the sulfated lactobionic acid (LW 10082) and other antithrombotic agents in animal thrombosis model.
    Giedrojć J; Krupiński K; Breddin HK; Bielawiec M
    Pol J Pharmacol; 1996; 48(3):317-22. PubMed ID: 9112669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.